Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 Vaccine
EBioMedicine
.
2022 May:79:104006.
doi: 10.1016/j.ebiom.2022.104006.
Epub 2022 Apr 14.
Authors
Beatrice Francavilla
1
,
Marzia Nuccetelli
2
,
Mariapia Guerrieri
3
,
Denise Fiorelli
2
,
Stefano Di Girolamo
3
Affiliations
1
Department of Otorhinolaryngology, University of Rome "Tor Vergata", Rome, Italy. Electronic address: beatrice.francavilla@ptvonline.it.
2
Department of Experimental Medicine, University of Tor Vergata, Rome, Italy.
3
Department of Otorhinolaryngology, University of Rome "Tor Vergata", Rome, Italy.
PMID:
35430452
PMCID:
PMC9009284
DOI:
10.1016/j.ebiom.2022.104006
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Viral
BNT162 Vaccine
COVID-19 Vaccines*
COVID-19* / prevention & control
Humans
Immunity, Mucosal
RNA, Messenger / genetics
Substances
Antibodies, Viral
COVID-19 Vaccines
RNA, Messenger
BNT162 Vaccine